The number of new graduates hired for sales rep roles increased in FY2025 after declining for five consecutive years, a…
HOME > REGULATORY
REGULATORY
- Number of Pharmacies Qualifying for Premiums for GE Drug Dispensing Systems Down in 2010
October 6, 2011
- MHLW Issues GL for Clinical Evaluation for Renal Anemia Drugs
October 5, 2011
- PMDA Invites Opinions on Candidate Drugs for JP Listing
October 5, 2011
- MHLW to Adopt Self-Evaluation by Generic Drug Makers for Stable Supply
October 5, 2011
- Korosho to Support Pharmacies’ Participation in Home Healthcare
October 5, 2011
- FPMAJ States Difficulty in Identifying Anticancer Drugs in Terms of Adverse Reactions
October 4, 2011
- MHLW Intends to Improve Self-sufficiency Ratio in HBIG Preparation
October 4, 2011
- Partial Change in Approval Is Not Necessary for 14 Products Including Allegra: PFSB
October 4, 2011
- Bill for Healthcare Reform for Elderly to Be Submitted to 2012 Diet: Health Minister
October 4, 2011
- METI Budget Request Includes ¥3.3 Bil. to Promote “Healthcare Industry Creation”
October 3, 2011
- Mr Akagawa of ELD Stresses Need for Closer East Asian Cooperation to Promote Multinational Trials
October 3, 2011
- Health Insurance Committee Unable to Agree on Proposed Fixed-sum Examination Fee
October 3, 2011
- Obama Administration’s Deficit-reduction Plan Calls For Shorter Exclusivity Period for Biologics
October 3, 2011
- Nat’l Medical Expenditure Rose 3.4% to Record ¥36,006.7 Billion in FY2009: MHLW
September 30, 2011
- MHLW Drug Subcommittee Withholds Approval of Additional Indication for Epogin
September 30, 2011
- MHLW to Request Perpetuation of “Add-on Credits,” “Credits for High-level R&D Investment”
September 29, 2011
- MHLW to Request Budget of ¥29,588.2 Bil., Special Framework Budget of ¥105.9 Bil. for FY2012
September 29, 2011
- CSIMC’s Committee to Assess Premium for New Drug Development Based on Results of Market Price Survey
September 29, 2011
- Record Number of New AIDS Cases Reported in 2nd Qtr. of 2011
September 28, 2011
- MHLW Approves 18 New Products
September 27, 2011
ページ
The traditional HR Business Partner (HRBP) model, once the gold standard for HR delivery, is undergoing a significant transformation. Many organizations, particularly in industries like pharmaceuticals, are moving towards a more agile resource model, aiming to streamline HR operations and…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s key reimbursement policy panel on December 25 approved an outline of the FY2025 drug price revision, finalizing plans to…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
A Japanese health ministry panel discussing the generic industry structure on May 22 put together a report in which it…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…
The Japanese health ministry’s expert panel tasked to discuss comprehensive policies for the rapid and stable supply of pharmaceuticals generally…